Skip to main content
SpringerLink
Log in

Controlling Emesis in Patients Receiving Cancer Chemotherapy

  • Conference paper
Supportive Care in Cancer Patients II

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 121))

Abstract

The decade of the 1980s proved to be an important period for the development of effective methods for controlling chemotherapy-induced emesis. Separate emetic problems were identified, an enhanced understanding of the physiology of emesis came about, effective agents were found, useful doses and schedules for these agents were established, combination regimens of greater efficacy were tested, and the ability to effectively prevent emesis was markedly improved.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kris MG, Tyson LB, Gralla RJ, et al. (1983) Extrapyramidal reactions with high-dose metoclopramide. N Engl J Med 309: 433

    PubMed  CAS  Google Scholar 

  2. Allen JC, Gralla RJ, Reilly C et al. (1985) Metoclopramide: dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy. J Clin Oncol 3: 1136–1141

    PubMed  CAS  Google Scholar 

  3. D’Acquisto RW, Tyson LB, Gralla RJ et al. (1986) The influence of a chronic high alcohol intake on chemotherapy-induced nausea and vomiting. Proc Am Soc Clin Oncol 5: 257

    Google Scholar 

  4. Sullivan JR, Leyden MJ, Bell R (1983) Decreased cisplatin induced nausea and vomiting with alcohol ingestion. N Engl J Med 309 (13): 796

    Article  PubMed  CAS  Google Scholar 

  5. Gralla RJ, Braun TJ, Squillante A et al. (1981) Metoclopramide: initial clinical studies of high dosage regimens in cisplatin-induced emesis. In: Poster D (ed) The treatment of nausea and vomiting induced by cancer chemotherapy. Masson, New York, pp 167–176

    Google Scholar 

  6. Roila F, Tonato M, Basurto C, et al. (1989) Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research. J Clin Oncol 7: 1693–1700

    PubMed  CAS  Google Scholar 

  7. Fetting JH, Grochow LB, Folstein MF et al. (1982) The course of nausea and vomiting after high-dose cyclophosphamide. Cancer Treat Rep 66: 1487–1493

    PubMed  CAS  Google Scholar 

  8. Mangioni C, Bolls G, Pecorelli et al. (1989) Randomized trial in advanced cancer comparing cisplatin and carboplatin. J Natl Cancer Inst 81: 1464–1471

    Article  PubMed  CAS  Google Scholar 

  9. Borison HL, McCarthy LE (1983) Neuropharmacology of chemotherapy induced emesis. Drugs 25: 8–17

    Article  PubMed  CAS  Google Scholar 

  10. Fozard JR: (1984) Neuronal 5-HT receptors in the periphery. Neuropharmacology 23: 1473–1486

    Article  PubMed  CAS  Google Scholar 

  11. Meyer BR, Lewin M, Dreyer DE et al. (1984) Optimizing metoclopramide control of cisplatin-induced emesis. Ann Intern Med 100: 393–395

    PubMed  CAS  Google Scholar 

  12. Gralla RJ, Itri LM, Pisko DE et al. (1981) Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med 305: 905–909

    Article  PubMed  CAS  Google Scholar 

  13. Gralla RJ, Tyson LB, Borden LB et al. (1984) Antiemetic therapy: a review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol. Cancer Treat Rep 68: 163–172

    PubMed  CAS  Google Scholar 

  14. Frustaci S, Tumolo S, Tirell U et al. (1983) High-dose metoclopramide versus dexamethasone in the prevention of cisplatin induced vomiting. Proc Am Soc Clin Oncol 2: 87

    Google Scholar 

  15. Aapro MS, Plezia PM, Alberts DS et al. (1983) Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone vs high-dose metoclopramide. Proc Am Soc Clin Oncol 2: 93

    Google Scholar 

  16. Grunberg SM, Gala KV, Lampenfeld M et al. (1984) Comparison of the antiemetic effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized double-blind crossover study. J Clin Oncol 2: 782–787

    PubMed  CAS  Google Scholar 

  17. Richards PD, Flaum MA, Bateman M et al. (1986) The antiemetic efficacy of secobarbital and promazine compared to metoclopramide, diphenhydramine, and dexamethasone. A randomized trial. Cancer 58: 959–962

    Google Scholar 

  18. Strum SB, McDermed JE, Opfell RW et al. (1982) Intravenous metoclopramide. An effective antiemetic in cancer chemotherapy. JAMA 247: 2683–2686

    Google Scholar 

  19. Tyson LB, Clark RA, Gralla RJ (1982) High-dose metoclopramide; control of dacarbazine-induced emesis in a preliminary trial. Cancer Treat Rep 66: 2108

    PubMed  CAS  Google Scholar 

  20. Gralla RJ, Tyson LB, Çlark RA et al. (1985) An all oral combination antiemetic regimen of patients receiving cytoxan + adriamycin + vincristine ( CAV ). Proc Am Soc Clin Oncol 4: 267

    Google Scholar 

  21. Anthony LB, Krozely MG, Woodward NJ et al. (1986) Antiemetic effect of oral versus intravenous metoclopramide in patients receiving cisplatin: a randomized double-blind trial. J Clin Oncol 4: 98–103

    PubMed  CAS  Google Scholar 

  22. Garnick MB (1983) Oral metoclopramide and cisplatin chemotherapy. Ann Intern Med 99: 127

    PubMed  CAS  Google Scholar 

  23. Clark RA, Gralla RJ, Kris MG, et al. (1989) Exploring very high doses of metoclopramide (4–6 mg/kg): preservation of efficacy and safety with only a single dose in a combination antiemetic regimen. Proc Am Soc Clin Oncol 8: 330

    Google Scholar 

  24. Von Hoff DD, Schilsky R, Reichert CM et al. (1979) Toxic effects of cisdichlorodiamineplatinum ( II) in man. Cancer Treat Rep 63: 1527–1531

    Google Scholar 

  25. Grossman B, Lessin LS, Cohen P (1979) Droperidol prevents nausea and vomiting from cis-platinum. N Engl J Med 301: 47

    PubMed  CAS  Google Scholar 

  26. Neidhart J, Gayden M, Metz E (1980) Haldol is an effective antiemetic for platinum and mustard induced vomiting when other agents fail. Proc Am Soc Clin Oncol 21: 365

    Google Scholar 

  27. Wampler G (1983) The pharmacology and clinical effectiveness of phenothiazines and related drugs for managing chemotherapy-induced emesis. Drugs 25: 35–51

    Article  PubMed  Google Scholar 

  28. Markman M, Sheidler V, Ettinger DS et al. (1984) Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy. N Engl J Med 311: 549–552

    Google Scholar 

  29. Frytak S, Moertel CG, O’Fallon J et al. (1979) Delta-9-tetrahydrocannabinol as an antiemetic in patients treated with cancer chemotherapy: a double comparison with prochlorperazine and a placebo. Ann Intern Med 91: 825–830

    PubMed  CAS  Google Scholar 

  30. Sallan SE, Cronin CM, Zelen M et al. (1980) Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine. N Engl J Med 302: 135–138

    Article  PubMed  CAS  Google Scholar 

  31. Orr LE, McKerman JF, Bloone B (1980) Antiemetic effect of tetrahydrocannabinol. Arch Intern Med 140: 1431–1433

    Article  PubMed  CAS  Google Scholar 

  32. Carr BI, Bertrand M, Browning S et al. (1985) A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatininduced emesis: a prospective randomized double-blind study. J Clin Oncol 3: 1127–1132

    PubMed  CAS  Google Scholar 

  33. Aapro MS, Alberts DS (1981) High-dose dexamethasone for prevention of cis-platinum induced vomiting. Cancer Chemother Pharmacol 7: 11–14

    Article  PubMed  CAS  Google Scholar 

  34. Lee BJ (1981) Methylprednisolone as an antiemetic. N Engl J Med 3034: 486

    Google Scholar 

  35. Cassileth PA, Lusk EJ, Torri S et al. (1983) Antiemetic efficacy of dexamethasone therapy in patients receiving cancer chemotherapy. Arch Intern Med 143: 13471349

    Google Scholar 

  36. Kris MG, Gralla RJ, Tyson LB et al. (1985) Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients. Cancer 55: 527–534

    Article  PubMed  CAS  Google Scholar 

  37. Kris MG, Gralla RJ, Clark RA et al. (1987) Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial. Cancer 60: 2816–2822

    Google Scholar 

  38. Laszlo J, Clark RA, Hanson DC et al. (1985) Lorazepam in cancer patients treated with cisplatin: a drug with antiemetic amnestic and anxiolytic effects. J Clin Oncol 3: 864–869

    PubMed  CAS  Google Scholar 

  39. Vincent BJ, McQuistion DJ, Einhorn LH et al. (1983) Review of cannabinoids and their antiemetic effectiveness. Drugs 25: 52–62

    Article  PubMed  Google Scholar 

  40. Tyson LB, Gralla RJ, Clark RA et al. (1985) Phase I trial of levonantradol in chemotherapy-induced emesis. Am J Clin Oncol 8: 528–532

    Article  PubMed  CAS  Google Scholar 

  41. Herman TS, Einhorn LH, Jones SE (1979) Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. N Engl J Med 300: 1295–1297

    Article  PubMed  CAS  Google Scholar 

  42. Steele N, Gralla RJ, Braun DW Jr (1980) Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis. Cancer Treat Rep 64: 219–224

    PubMed  CAS  Google Scholar 

  43. Chang AE, Shiling DJ, Stillman RC et al. (1979) Delta-9-tetrahydrocannabinol as an antiemetic in patients receiving high-dose methotrexate: a prospective randomized evaluation. Ann Intern Med 91: 819–824

    PubMed  CAS  Google Scholar 

  44. Venner P, Bruera E, Drebit D et al. (1986) Intensive treatment of scheduling of nabilone (N) plus dexamethasone (DM) vs. metoclopramide (M) plus DM in cisplatinum ( CP)-induced emesis. Proc Am Soc Clin Oncol 5: 253

    Google Scholar 

  45. Allan SG, Cornbleet MA, Warrington PS et al. (1984) Dexamethasone and high-dose metoclopramide: efficacy in controlling cisplatin-induced nausea and vomiting. Br Med J 289: 878–879

    Article  CAS  Google Scholar 

  46. Rosell R, Abad-Esteve A, Ribas-Mundo M et al. (1985) Evaluation of a combination antiemetic regimen including IV high-dose metoclopramide, dexamethasone, and diphenhydramine in cisplatin-based chemotherapy regimens. Cancer Treat Rep 69: 909–910

    PubMed  CAS  Google Scholar 

  47. Mason BA, Dambra J, Grossman B et al. (1982) Effective control of cisplatininduced nausea using high-dose steroids and droperidol. Cancer Treat Rep 66: 243–245

    PubMed  CAS  Google Scholar 

  48. Cunningham D, Popic A, Ford I et al. (1987) Prevention of emesis in patients receiving cytotoxic drugs by GR38032F, a selective 5-HT3 receptor antagonist. Lancet: 1461–1462

    Google Scholar 

  49. Kris MG, Gralla RJ, Clark RA et al. (1988) Dose-ranging evaluation of the serotonin antagonist GR-C507/75 (GR38032F) when used as an antiemetic in patients receiving anticancer chemotherapy. J Clin Oncol 6: 659–662

    PubMed  CAS  Google Scholar 

  50. Addelman M, Erlichman C, Fine S et al. (1990) Phase I/II trial of granisetron: a novel 5-hydroxytryptamine antagonist for the prevention of chemotherapy-induced nausea and vomiting. J Clin Oncol 8: 337–341

    PubMed  CAS  Google Scholar 

  51. Joss R, Rohrback D, Pirovino M et al. (1988) BRL 43694: a novel antiemetic to prevent chemotherapy (CT)-induced nausea ( N) and vomiting (V ). Lung Cancer 4: A181

    Google Scholar 

  52. Tyson LR, Gralla RJ, Kris MG et al. (1989) Phase I antiemetic study of the serotonin antagonist ICS 205–930. Proc Am Soc Clin Oncol 8: 331

    Google Scholar 

  53. Stamatakis L, Michel J, Van Belle Set al. (1989) ICS 205–930: a dose finding study in the prevention of cisplatin induced nausea and vomiting. Proc Am Soc Clin Oncol 8: 327

    Google Scholar 

  54. Smaldone L, Fairchild C, Rozencweig M et al. (1988) Dose-range evaluation of BMY-25801, a non-dopaminergic antiemetic. Proc Am Soc Clin Oncol 7: 280

    Google Scholar 

  55. Wilcox PM, Fetting JH, Nettesheim KM et al. (1982) Anticipatory vomiting in women receiving cyclophosphamide, methotrexate and 5-FU ( CMF) adjuvant chemotherapy for breast carcinoma. Cancer Treat Rep 66: 1601–1604

    Google Scholar 

  56. Morrow GR (1982) Prevalence and correlates of anticipatory nausea and vomiting in chemotherapy patients. J Natl Cancer Inst 68: 585–588

    PubMed  CAS  Google Scholar 

  57. Morrow GR, Morrel C (1982) Behavioral treatment for the anticipatory nausea and vomiting induced by cancer chemotherapy. N Engl J Med 307: 1476–1480

    Article  PubMed  CAS  Google Scholar 

  58. Kris MG, Gralla RJ, Clark RA et al. (1985) Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin. J Clin Oncol 3: 1379–1384

    PubMed  CAS  Google Scholar 

  59. Strum S, McDermed J, Abrahano-Umali R et al. (1985) Management of cisplatin (DDP)-induced delayed-onset nausea (N) and vomiting (V): preliminary results with two drug regimens. Proc Am Soc Clin Oncol 4: 263

    Google Scholar 

  60. Kris MG, Gralla RJ, Tyson LB et al. (1989) Controlling delayed vomiting: double-blind randomized trial comparing placebo, dexamethasone alone and metoclopramide plus dexamethasone in patients receiving cisplatin. J Clin Oncol 7: 108–114

    PubMed  CAS  Google Scholar 

  61. Gralla RJ, Kris MG, Tyson LB, Clark RA (1988) Controlling emesis in patients receiving cancer chemotherapy. In: Senn HJ, Glaus A, Schmid L (eds) Supportive care in cancer patients. Springer, Berlin Heidelberg New York, pp 89–101

    Chapter  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ochsner Cancer Institute, Ochsner Medical Institutions, 1516 Jefferson Highway, New Orleans, LA, 70121, USA

    R. J. Gralla

Authors
  1. R. J. Gralla
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Klinik C, Kantonsspital St. Gallen, 9007, St. Gallen, Switzerland

    Hans-Jörg Senn  & Agnes Glaus  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Gralla, R.J. (1991). Controlling Emesis in Patients Receiving Cancer Chemotherapy. In: Senn, HJ., Glaus, A. (eds) Supportive Care in Cancer Patients II. Recent Results in Cancer Research, vol 121. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84138-5_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-84138-5_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-84140-8

  • Online ISBN: 978-3-642-84138-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation